DENVER, April 26, 2022 (GLOBE NEWSWIRE) — Assure Holdings, a provider of intraoperative neuromonitoring and remote neurology services, announced the appointment of James Watt to the position of national technologist director. Mr. Watt reports to Assure’s vice president of clinical operations, Stephanie Krouse.
In his new role, Mr. Watt leads day-to-day operations for Assure’s clinical technologist team, ensuring quality of service and overseeing the Company’s training and development program. In addition, Mr. Watt will play an important role in the establishment of new competencies that will drive Assure’s expansion into adjacent markets such as electroencephalogram (“EEG”) as well as the creation of a Deep Brain Stimulation (“DBS”) program.
“James is exceptionally experienced in the IONM industry, widely regarded as a leader in our industry’s most important societies and organizations, and he maintains extensive relationships with surgeons and hospitals,” said John A. Farlinger, Assure’s executive chairman and CEO. “In addition, James is an operationally oriented leader with a track record of success improving his team’s clinical efficiencies, providing high quality education and training, and most importantly, facilitating exceptional patient care.”
On his appointment, Mr. Watt commented, “I am fully aligned with Assure’s commitment to providing exceptional clinical care and improved patient outcomes and excited to support the Company’s expansion into EEG, DBS and other remote neurology markets.”
Mr. Watt has 25 years of experience in the IONM industry, most recently serving as chief innovation officer and chief operating officer at Advanced Monitoring Services. Prior to that, he was the vice president of neuromonitoring services at Comprehensive Care Services and clinical product designer at Biotronic NeuroNetwork (now part of NuVasive). In addition, Mr. Watt is president-elect of the Southern Neurodiagnostic Society (SSET) and a past board member at the American Society of Neurophysiological Monitoring (ASNM). He has also been a featured speaker at regional and national neurodiagnostic societies including The Neurodiagnostic Society (ASET) and the Central Society of Electroneurodiagnostic Technologists (CSET) and a teacher of neurodiagnostics in Africa and elsewhere lacking skilled professionals in the field. Mr. Watt earned a Bachelor of Science in Biology from Spring Arbor University and has earned a certification for neurophysiological intraoperative monitoring (CNIM), is a registered evoked potential technologist (R. EP T.) and is a Fellow of American Society of Neuromonitoring (F.ASNM), recognized and voted on by the society for being a true leader and educator.
About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.